These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23625828)

  • 1. Induced adaptation of Bacillus sp. to antimicrobial nanosilver.
    Gunawan C; Teoh WY; Marquis CP; Amal R
    Small; 2013 Nov; 9(21):3554-60. PubMed ID: 23625828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication, characterization of chitosan/nanosilver film and its potential antibacterial application.
    Thomas V; Yallapu MM; Sreedhar B; Bajpai SK
    J Biomater Sci Polym Ed; 2009; 20(14):2129-44. PubMed ID: 19874682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological effects and possible modes of action of nanosilver.
    Völker C; Oetken M; Oehlmann J
    Rev Environ Contam Toxicol; 2013; 223():81-106. PubMed ID: 23149813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosilver and the microbiological activity of the particulate solids versus the leached soluble silver.
    Faiz MB; Amal R; Marquis CP; Harry EJ; Sotiriou GA; Rice SA; Gunawan C
    Nanotoxicology; 2018 Apr; 12(3):263-273. PubMed ID: 29447029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture.
    Sahu SC; Zheng J; Graham L; Chen L; Ihrie J; Yourick JJ; Sprando RL
    J Appl Toxicol; 2014 Nov; 34(11):1155-66. PubMed ID: 24522958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation and antibacterial properties of heparinized nanosilver with different morphologies.
    Meher MK; Poluri KM
    Carbohydr Polym; 2021 Aug; 266():118124. PubMed ID: 34044940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal mediated biosynthesis of silver nanoparticles, characterization and antimicrobial activity.
    Jaidev LR; Narasimha G
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):430-3. PubMed ID: 20708910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread and Indiscriminate Nanosilver Use: Genuine Potential for Microbial Resistance.
    Gunawan C; Marquis CP; Amal R; Sotiriou GA; Rice SA; Harry EJ
    ACS Nano; 2017 Apr; 11(4):3438-3445. PubMed ID: 28339182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial properties of uncapped silver nanoparticles synthesized by DC arc thermal plasma technique.
    Shinde M; Patil R; Karmakar S; Bhoraskar S; Rane S; Gade W; Amalnerkar D
    J Nanosci Nanotechnol; 2012 Feb; 12(2):887-93. PubMed ID: 22629869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of antibacterial multilayer films containing nanosilver via layer-by-layer assembly of heparin and chitosan-silver ions complex.
    Fu J; Ji J; Fan D; Shen J
    J Biomed Mater Res A; 2006 Dec; 79(3):665-74. PubMed ID: 16832825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activity of nanosilver ions and particles.
    Sotiriou GA; Pratsinis SE
    Environ Sci Technol; 2010 Jul; 44(14):5649-54. PubMed ID: 20583805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalgae mediated synthesis of silver nanoparticles and their antibacterial activity against pathogenic bacteria.
    Sudha SS; Rajamanickam K; Rengaramanujam J
    Indian J Exp Biol; 2013 May; 51(5):393-9. PubMed ID: 23821828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchrotron FTIR microspectroscopy of the yeast Saccharomyces cerevisiae after exposure to plasma-deposited nanosilver-containing coating.
    Saulou C; Jamme F; Maranges C; Fourquaux I; Despax B; Raynaud P; Dumas P; Mercier-Bonin M
    Anal Bioanal Chem; 2010 Feb; 396(4):1441-50. PubMed ID: 20012742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalgae associated Brevundimonas sp. MSK 4 as the nano particle synthesizing unit to produce antimicrobial silver nanoparticles.
    Rajamanickam K; Sudha SS; Francis M; Sowmya T; Rengaramanujam J; Sivalingam P; Prabakar K
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Sep; 113():10-4. PubMed ID: 23711394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver nanoparticles in aquatic environments: Physiochemical behavior and antimicrobial mechanisms.
    Zhang C; Hu Z; Deng B
    Water Res; 2016 Jan; 88():403-427. PubMed ID: 26519626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of nanosilver surface modification to RO membrane and spacer for mitigating biofouling in seawater desalination.
    Yang HL; Lin JC; Huang C
    Water Res; 2009 Aug; 43(15):3777-86. PubMed ID: 19586651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology and antibacterial activity of carbohydrate-stabilized silver nanoparticles.
    Valodkar M; Bhadoria A; Pohnerkar J; Mohan M; Thakore S
    Carbohydr Res; 2010 Aug; 345(12):1767-73. PubMed ID: 20591419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial effects and protein corona evaluations: crucial ignored factors in the prediction of bio-efficacy of various forms of silver nanoparticles.
    Ashkarran AA; Ghavami M; Aghaverdi H; Stroeve P; Mahmoudi M
    Chem Res Toxicol; 2012 Jun; 25(6):1231-42. PubMed ID: 22551528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cytotoxic silver nanoparticle-polysaccharide nanocomposites with antimicrobial activity.
    Travan A; Pelillo C; Donati I; Marsich E; Benincasa M; Scarpa T; Semeraro S; Turco G; Gennaro R; Paoletti S
    Biomacromolecules; 2009 Jun; 10(6):1429-35. PubMed ID: 19405545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitigation of Obesity-Related Systemic Low-Grade Inflammation and Gut Microbial Dysbiosis in Mice with Nanosilver Supplement.
    Jia J; Zhang W; Wu Y; Zhang X; Li C; Wang J; Yan B
    ACS Appl Bio Mater; 2021 Mar; 4(3):2570-2582. PubMed ID: 35014374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.